Scientific Study Title: Mapping anti-mitochondrial antibodies in systemic lupus erythematosus

 

Principal Investigator: Paul R Fortin, MD, MPH, FRCPC. CHU de Québec – Université Laval Research Centre

 

Study Start Date:  2019/01   Study End Date:  2022/01

 

Why do this research? Lupus or systemic lupus erythematosus (SLE) is a complex and unpredictable disease that can lead to irreversible organ damage. Patients with lupus have specific proteins in their blood that are absent in healthy people. Researchers believe that these proteins could represent a new signal for diagnosing and understanding lupus.

 

Our goals are to:

(1) Measure the presence of 10 different specific proteins in this group of lupus patients;

(2) define which of the 10 proteins is linked with lupus.

 

What will be done? We will study blood samples and clinical data from a large group of lupus patients followed since the time of their diagnosis at yearly intervals between years 2000 and 2018.

 

Who is involved? Scientists, a biostatistician, a patient representative, and lupus patients.

 

Co-investigators: Michal Abrahamowicz, Eric Boilard, Joyce Rauch

 

Research Staff: A senior Research Coordinator, a laboratory technician, a biostatistician, a doctoral student, and a bachelor student.

 

Funding Agency:  Canadian Institutes of Health Research

Share This

Share on Social Media

Share a message of hope...

Share This

Share this post with your friends!